Global Cancer Gene Panel and Profiling Market Research Report: Forecast (2024-2029)

By Technology (Next-generation Sequencing [NGS], Polymerase Chain Reaction [PCR], Microarray, Mass Spectrometry, Others), By Application (Oncology Research, Personalized Medicine, Drug Development, Cl... ... Drug Development, Clinical Diagnostics), By Cancer Type (Breast Cancer, Lung Cancer, Prostrate Cancer, Colorectal Cancer, Others) , By Cell Type (Germline, Somatic), By End-User (Hospital & Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other) Read more

  • Healthcare
  • Oct 2023
  • 192
  • PDF, Excel, PPT

Market Definition

Cancer gene panel & profiling is a genetic testing method that focuses on analyzing a specific set of genes associated with a particular condition or disease. It involves sequencing & analyzing the DNA within these selected genes to identify potential variations, mutations, or alterations that may be linked to the condition under investigation. Gene profiling testing refers to the comprehensive analysis of multiple genes or gene expression patterns to gain insights into various biological processes, disease states, or responses to treatments. Both gene panel testing & gene profiling testing play crucial roles in genomics research, personalized medicine, and clinical diagnostics by providing insights into genetic variations, gene expression patterns, and their implications for health and disease.

Market Insights & Projections: Global Cancer Gene Panel and Profiling Market (2024-29):

The Global Cancer Gene Panel & Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29. The exponential increase in the incidence of cancer has emerged as a key driver propelling the market growth for cancer gene panels & profiling testing services. For instance, according to the Global Cancer Observatory, in 2022, there were approximately 19.3 million new cases & 10.3 million deaths due to cancer all across the globe. Breast Cancer in females surpassed lung cancer in 2020, thereby becoming the most common type of diagnosed cancer with 11.7% prevalence, followed by lung cancer at 11.4%, colon cancer at 10%, prostate cancer at 7.3%, and stomach cancer at 5.6%.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-29
CAGR (2024-2029) 15.5%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Singapore, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled 10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other
Unit Denominations USD Million/Billion

 

This surge has led to the escalating demand for advanced diagnostic testing procedures for the early detection & monitoring of cancer cases. Consequently, oncologists have progressively embraced the utilization of genetic testing methodologies such as gene panels & profiling to discern crucial factors like disease stage, hereditary predisposition, and tailored therapeutic approaches.

Moreover, the realm of genetic testing has also been observed to play a pivotal role in enabling oncologists to accurately ascertain the precise stage of cancer within patients, thereby facilitating more effective and targeted treatment strategies. Hence, to capitalize on this plethora of advantages, healthcare professionals started inclining toward genetic profiling & panel testing, which has distinctly bolstered the growth trajectory of this market.

Global Cancer Gene Panel and Profiling Market Research Report (2024-2029) - Table of Contents

 

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Genome Sequencing Revolution, 2000-2022
  5. Global Cancer Gene Panel and Profiling Clinical Trial Analysis, 2019-2023
  6. Global Cancer Gene Panel and Profiling Market Trends & Developments
  7. Global Cancer Gene Panel and Profiling Market Dynamics
    1. Drivers
    2. Challenges
  8. Global Cancer Gene Panel and Profiling Market Regulation, Policy & Standards
  9. Global Cancer Gene Panel and Profiling Market Hotspot and Opportunities
  10. Global Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Size & Analysis
      1. By Technology
        1. Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million
        2. Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million
        3. Microarray- Market Size & Forecast 2019-2029, USD Million
        4. Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million
        5. Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million
      2. By Application
        1. Oncology Research- Market Size & Forecast 2019-2029, USD Million
        2. Personalized Medicine- Market Size & Forecast 2019-2029, USD Million
        3. Drug Development- Market Size & Forecast 2019-2029, USD Million
        4. Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type
        1. Breast Cancer- Market Size & Forecast 2019-2029, USD Million
        2. Lung Cancer- Market Size & Forecast 2019-2029, USD Million
        3. Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million
        4. Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million
        5. Others (Ovarian Cancer, Leukemia, etc.) - Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type
        1. Germline - Market Size & Forecast 2019-2029, USD Million
        2. Somatic - Market Size & Forecast 2019-2029, USD Million
      5. By End-User
        1. Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million
        2. Research Institutes- Market Size & Forecast 2019-2029, USD Million
        3. Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million
        4. Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      7. By Company
        1. Competition Characteristics
        2. Revenue Shares & Analysis
  11. North America Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. Canada Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    5. Mexico Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  12. South America Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  13. Europe Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of Europe
    3. Germany Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. The UK Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    5. France Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    6. Spain Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    7. Italy Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  14. Middle East & Africa Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. GCC
        2. South Africa
        3. Rest of Middle East & Africa
    3. GCC Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. South Africa Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  15. Asia-Pacific Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. China
        2. Japan
        3. South Korea
        4. India
        5. Australia
        6. Rest of Asia Pacific
    3. China Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. Japan Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    5. South Korea Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    6. India Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    7. Australia Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  16. Global Cancer Gene Panel and Profiling Market Key Strategic Imperatives for Success & Growth
  17. Competitive Outlook
    1. Company Profiles 
      1. 10x Genomics, Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
      2. Caris Lifescience
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Neo genomics
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Flugent Genetics
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Centogene N.V.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Geneseeq Technology Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Variantyx
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Genetron Holdings Limited
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Laboratory Corporation of America® Holdings (LabCorp)
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. H.T. G Molecular
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Bio array Diagnostic genetic
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Biorad laboratories Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Enzo Lifesciences
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Eurofins Scientific
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Nanostring Technologies
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .